TY - JOUR
T1 - Identification of residues important for agonist recognition and activation in GPR40
AU - Chi, Shing Sum
AU - Tikhonova, Irina G.
AU - Neumann, Susanne
AU - Engel, Stanislav
AU - Raaka, Bruce M.
AU - Costanzi, Stefano
AU - Gershengorn, Marvin C.
PY - 2007/10/5
Y1 - 2007/10/5
N2 - GPR40 was formerly an orphan G protein-coupled receptor whose endogenous ligands have recently been identified as free fatty acids (FFAs). The receptor, now named FFA receptor 1, has been implicated in the pathophysiology of type 2 diabetes and is a drug target because of its role in FFA-mediated enhancement of glucose-stimulated insulin release. Guided by molecular modeling, we investigated the molecular determinants contributing to binding of linoleic acid, a C18 polyunsaturated FFA, and GW9508, a synthetic small molecule agonist. Twelve residues within the putative GPR40-binding pocket including hydrophilic/ positively charged, aromatic, and hydrophobic residues were identified and were subjected to site-directed mutagenesis. Our results suggest that linoleic acid and GW9508 are anchored on their carboxylate groups by Arg183, Asn244, and Arg258. Moreover, His86, Tyr 91, and His137 may contribute to aromatic and/or hydrophobic interactions with GW9508 that are not present, or relatively weak, with linoleic acid. The anchor residues, as well as the residues Tyr 12, Tyr91, His137, and Leu186, appear to be important for receptor activation also. Interestingly, His 137 and particularly His86 may interact with GW9508 in a manner dependent on its protonation status. The greater number of putative interactions between GPR40 and GW9508 compared with linoleic acid may explain the higher potency of GW9508.
AB - GPR40 was formerly an orphan G protein-coupled receptor whose endogenous ligands have recently been identified as free fatty acids (FFAs). The receptor, now named FFA receptor 1, has been implicated in the pathophysiology of type 2 diabetes and is a drug target because of its role in FFA-mediated enhancement of glucose-stimulated insulin release. Guided by molecular modeling, we investigated the molecular determinants contributing to binding of linoleic acid, a C18 polyunsaturated FFA, and GW9508, a synthetic small molecule agonist. Twelve residues within the putative GPR40-binding pocket including hydrophilic/ positively charged, aromatic, and hydrophobic residues were identified and were subjected to site-directed mutagenesis. Our results suggest that linoleic acid and GW9508 are anchored on their carboxylate groups by Arg183, Asn244, and Arg258. Moreover, His86, Tyr 91, and His137 may contribute to aromatic and/or hydrophobic interactions with GW9508 that are not present, or relatively weak, with linoleic acid. The anchor residues, as well as the residues Tyr 12, Tyr91, His137, and Leu186, appear to be important for receptor activation also. Interestingly, His 137 and particularly His86 may interact with GW9508 in a manner dependent on its protonation status. The greater number of putative interactions between GPR40 and GW9508 compared with linoleic acid may explain the higher potency of GW9508.
UR - http://www.scopus.com/inward/record.url?scp=35748937333&partnerID=8YFLogxK
U2 - 10.1074/jbc.M705077200
DO - 10.1074/jbc.M705077200
M3 - Article
AN - SCOPUS:35748937333
SN - 0021-9258
VL - 282
SP - 29248
EP - 29255
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 40
ER -